231 related articles for article (PubMed ID: 9837868)
1. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
Praticò D; MY Lee V; Trojanowski JQ; Rokach J; Fitzgerald GA
FASEB J; 1998 Dec; 12(15):1777-83. PubMed ID: 9837868
[TBL] [Abstract][Full Text] [Related]
2. Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia.
Yao Y; Zhukareva V; Sung S; Clark CM; Rokach J; Lee VM; Trojanowski JQ; Praticò D
Neurology; 2003 Aug; 61(4):475-8. PubMed ID: 12939420
[TBL] [Abstract][Full Text] [Related]
3. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
[TBL] [Abstract][Full Text] [Related]
4. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA.
Iuliano L; Praticò D; Greco C; Mangieri E; Scibilia G; FitzGerald GA; Violi F
J Am Coll Cardiol; 2001 Jan; 37(1):76-80. PubMed ID: 11153776
[TBL] [Abstract][Full Text] [Related]
5. Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.
Durazzo TC; Korecka M; Trojanowski JQ; Weiner MW; O' Hara R; Ashford JW; Shaw LM;
J Alzheimers Dis; 2016 Jul; 54(1):99-107. PubMed ID: 27472882
[TBL] [Abstract][Full Text] [Related]
6. Increased CSF F2-isoprostane concentration in probable AD.
Montine TJ; Beal MF; Cudkowicz ME; O'Donnell H; Margolin RA; McFarland L; Bachrach AF; Zackert WE; Roberts LJ; Morrow JD
Neurology; 1999 Feb; 52(3):562-5. PubMed ID: 10025788
[TBL] [Abstract][Full Text] [Related]
7. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
[TBL] [Abstract][Full Text] [Related]
8. Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
Reilly MP; Praticò D; Delanty N; DiMinno G; Tremoli E; Rader D; Kapoor S; Rokach J; Lawson J; FitzGerald GA
Circulation; 1998 Dec 22-29; 98(25):2822-8. PubMed ID: 9860782
[TBL] [Abstract][Full Text] [Related]
9. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
10. Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò D; Iuliano L; Mauriello A; Spagnoli L; Lawson JA; Rokach J; Maclouf J; Violi F; FitzGerald GA
J Clin Invest; 1997 Oct; 100(8):2028-34. PubMed ID: 9329967
[TBL] [Abstract][Full Text] [Related]
11. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease.
Tuppo EE; Forman LJ; Spur BW; Chan-Ting RE; Chopra A; Cavalieri TA
Brain Res Bull; 2001 Mar; 54(5):565-8. PubMed ID: 11397549
[TBL] [Abstract][Full Text] [Related]
12. Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients.
Praticò D; Yao Y; Rokach J; Mayo M; Silverberg GG; McGuire D
J Alzheimers Dis; 2004 Aug; 6(4):385-9; discussion 443-9. PubMed ID: 15345808
[TBL] [Abstract][Full Text] [Related]
13. IPF2alpha-I: an index of lipid peroxidation in humans.
Praticò D; Barry OP; Lawson JA; Adiyaman M; Hwang SW; Khanapure SP; Iuliano L; Rokach J; FitzGerald GA
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3449-54. PubMed ID: 9520386
[TBL] [Abstract][Full Text] [Related]
14. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
Praticò D; Basili S; Vieri M; Cordova C; Violi F; Fitzgerald GA
Am J Respir Crit Care Med; 1998 Dec; 158(6):1709-14. PubMed ID: 9847257
[TBL] [Abstract][Full Text] [Related]
15. Brain isoprostanes: a marker of lipid peroxidation and oxidative stress in AD.
Irizarry MC; Hyman BT
Neurology; 2003 Aug; 61(4):436-7. PubMed ID: 12939413
[No Abstract] [Full Text] [Related]
16. [Isoprostanes: new markers of oxidative stress in human diseases].
Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
[TBL] [Abstract][Full Text] [Related]
17. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
[TBL] [Abstract][Full Text] [Related]
18. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.
Reilly MP; Delanty N; Roy L; Rokach J; Callaghan PO; Crean P; Lawson JA; FitzGerald GA
Circulation; 1997 Nov; 96(10):3314-20. PubMed ID: 9396422
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
Montine TJ; Markesbery WR; Morrow JD; Roberts LJ
Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry.
Adiyaman M; Lawson JA; Khanapure SP; FitzGerald GA; Rokach J
Anal Biochem; 1998 Aug; 262(1):45-56. PubMed ID: 9735147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
